Only about 12% of US adults met criteria for optimal metabolic health in a 2019 analysis of national survey data published in Metabolic Syndrome and Related Disorders. Meanwhile, the CDC reports that roughly 6 in 10 adults live with at least one chronic disease. People are increasingly looking for ways to prevent illness rather than only treat it, and an industry has grown to meet them.
Health and wellness trends now move quickly. Wearables track sleep and heart rate. GLP-1 medications have changed the conversation about weight. Longevity clinics sell advanced testing. Strength training, once niche, has become mainstream guidance. KFF polling in 2024 found that about 1 in 8 US adults had taken a GLP-1 medication, a sign of how fast a medical trend can reach the public.
Not every trend deserves the same trust. Some rest on decades of randomized trials, such as physical activity and blood pressure control. Others are expanding technologies with promising but incomplete evidence. Some are preliminary research ideas, and some are marketing language. The 15 trends below are sorted by what is known, what is emerging and what remains unproven. Consumer interest does not prove health benefit, and trends are not medical recommendations.
Why Health and Wellness Are Changing
Several forces overlap. Populations are aging, chronic disease is common, and mental health needs have risen. Lifestyles are more sedentary, and food environments are heavy in ultra-processed products. Many people struggle to access primary care, which pushes them toward direct-to-consumer options.
Consumers want personalization and convenience. They expect apps, home tests and virtual visits. Technology makes it cheap to collect data, and investors have funded companies that sell insight. A large commercial wellness market has emerged, with estimates from industry groups reaching trillions of dollars, though methods differ and figures should be treated cautiously.
Scientific progress also contributes. Large cohorts, better imaging, new drugs and wearable sensors generate evidence faster. The challenge is separating signal from marketing noise.
15 Health and Wellness Trends Shaping Wellbeing
Each trend is rated by evidence maturity. Established means supported by consistent trial or cohort evidence. Expanding means growing use with partial evidence. Emerging means early research. Commercial means promotion outpaces evidence.
Each trend below is labeled by maturity: established means consistent trial or cohort evidence supports it, expanding means use is growing while evidence is partial, emerging means research is early, and commercial means promotion outpaces proof. Company examples describe what each organization contributes, and they are not endorsements. Market estimates vary by definition.
The Global Wellness Institute, for example, estimated the global wellness economy at about $6.8 trillion in 2024 and forecast about $9.8 trillion by 2029, a broad figure that includes categories such as beauty, travel and fitness, so it should not be read as health spending.
1. Personalized preventive healthcare
Maturity: expanding.
Personalized prevention means tailoring screening and risk reduction to a person’s age, family history, risk factors and preferences. The established core is guideline based care, such as the US Preventive Services Task Force recommendations for blood pressure, cholesterol, diabetes and cancer screening, plus cardiovascular risk calculators. Newer additions include polygenic risk scores, extended lipid testing and coronary artery calcium scoring. The scientific basis is strongest where a test changes treatment, for example using a calcium score to decide on statin therapy in borderline cases.
Examples of how it appears: Function Health and Superpower sell consumer blood testing memberships, while hospital executive health programs such as Mayo Clinic’s combine screening with specialist review. The intended audience is health conscious adults and people with a family history of early disease. Limits include cost, uneven access and the fact that polygenic scores predict less well in people of non European ancestry. For employers and health systems, the implication is that prevention works best when results link to follow up care and not when they stop at a report.
2. Longevity and healthspan focused care
Maturity: emerging, with an established core.
Healthspan means years lived in good health. A 2024 analysis by Mayo Clinic researchers in JAMA Network Open estimated that the gap between lifespan and healthspan in the United States was about 12 years, the widest among 183 countries studied, which is a driver of interest. Longevity clinics respond with advanced testing, imaging and personalized plans, as profiled in a companion article on US clinics.
The proven parts are exercise, blood pressure and lipid control, smoking cessation and nutrition. The less proven parts include whole body MRI screening, which the American College of Radiology has said lacks evidence in people without symptoms, epigenetic age tests and experimental drugs such as rapamycin and senolytics. Companies include Fountain Life, Human Longevity and Biograph. The audience is mostly affluent adults, which raises equity concerns. For wellness businesses, the opportunity is real, and the risk is overpromising. Claims that a clinic can reverse aging are not supported by human outcome data.
3. Preventive diagnostics and risk assessment
Maturity: mixed.
This trend covers tests that look for disease risk before symptoms appear, including coronary artery calcium scoring, extended lipid and inflammation markers, home screening kits and multi cancer early detection blood tests. Calcium scoring has decades of evidence for risk refinement. Multi cancer blood tests, such as GRAIL’s Galleri, are marketed as laboratory developed tests, and large trials including the NHS-Galleri study are evaluating whether they reduce late stage cancers. As of the latest information verified for this article, they are not FDA approved for screening.
Consumers meet the trend through direct to consumer lab panels and imaging centers such as Prenuvo. Benefits include earlier detection for some conditions. Risks include false positives, overdiagnosis and follow up procedures that carry harm. The implication for health systems is the need for clear pathways for abnormal results, and for employers it is caution about paying for broad screening without evidence.
4. Metabolic health monitoring
Maturity: expanding.
Metabolic health refers to markers such as blood glucose, blood pressure, waist circumference and lipids. A 2019 analysis in Metabolic Syndrome and Related Disorders found that only about 12 percent of US adults met criteria for optimal metabolic health, which explains the demand. In 2024 the FDA cleared the first over the counter continuous glucose monitors, Dexcom’s Stelo and Abbott’s Lingo, making sensors available without a prescription to people who do not use insulin.
The related shift is GLP-1 medication. The SELECT trial showed that semaglutide reduced major cardiovascular events by about 20 percent in adults with obesity and established heart disease, and KFF polling in 2024 found about 1 in 8 US adults had ever taken a GLP-1 drug. Companies include Abbott, Dexcom, Nutrisense and Levels on the monitoring side and Lilly and Novo Nordisk on the drug side. Evidence is strong for people with diabetes and approved obesity indications, and weaker for healthy users who wear glucose sensors. Limits include cost, supply and misinterpretation of normal glucose fluctuations.
5. Remote patient monitoring
Maturity: expanding.
Remote patient monitoring uses connected devices at home, such as blood pressure cuffs, glucose meters and scales, to send readings to a care team. Trials of self monitored blood pressure with clinician support, such as the TASMINH4 trial in The Lancet, show better control than usual care. Medicare pays for remote monitoring through specific billing codes, and uptake has grown quickly, which has drawn attention from the HHS Office of Inspector General about oversight in 2024.
Companies include Cadence, which pairs devices with nurses, and Omada and Teladoc Health’s chronic care programs. Health systems use remote monitoring for hypertension, heart failure and post discharge care. Benefits include earlier intervention. Barriers include alert fatigue, patient engagement and reimbursement rules. For clinicians, success depends on workflows that triage readings, and for employers, evidence of savings is stronger in specific high risk groups than across all employees.
6. AI powered health monitoring
Maturity: emerging to expanding.
AI health monitoring analyzes sensor, imaging and record data to flag risk or suggest actions. The FDA’s public list of AI enabled medical devices has passed 1,200 entries, with the majority in radiology, which shows that regulated AI is concentrated in clinical imaging, while consumer AI coaching is mostly unregulated. The American Medical Association reported that 66 percent of US physicians used health AI tools in 2024, mostly for documentation and administrative tasks.
Examples include imaging triage tools, ambient clinical documentation from companies such as Abridge, and wearable features that alert users to heart rhythm irregularities. Benefits include speed and scale. Risks include bias, false alarms, unclear accountability and privacy. Evidence varies by use, and many tools have been evaluated retrospectively and not in trials of patient outcomes. Consumers should treat AI recommendations as prompts for conversation with a clinician.
7. Wearable health technology
Maturity: mature market, with expanding clinical features.
Wearables include smartwatches, rings and bands that track activity, heart rate, sleep and temperature. Pew Research found in 2020 that about one in five US adults regularly wore a smartwatch or fitness tracker, and adoption has grown since. Some features carry regulatory clearance, such as the Apple Watch’s irregular rhythm detection, sleep apnea notifications authorized in 2024 and hypertension notifications cleared in 2025, though these are screening alerts and not diagnoses.
Oura, Whoop, Garmin, Samsung and Fitbit compete on sensors and software. Benefits include awareness and motivation, and large datasets for research. Limits include accuracy variation, especially for sleep stages and calorie estimates, anxiety from constant data and uneven access because of cost. Employers use wearables in wellness challenges, though privacy and voluntary participation matter. Wearable data complement but do not replace clinical measurement.
8. Sleep optimization technology
Maturity: expanding, with strong evidence for specific treatments.
Sleep products include trackers, smart mattresses, light and sound devices and digital programs. The strongest treatment evidence is for cognitive behavioral therapy for insomnia, recommended as first line care by the American College of Physicians, and digital versions such as Sleepio have randomized trial support, with FDA clearance for the prescription version SleepioRx in 2024. CPAP remains the standard therapy for obstructive sleep apnea.
Eight Sleep and Sleep Number sell temperature controlled and sensor equipped beds, and Oura and Apple provide trackers. Consumer sleep stage data are estimates, and more data do not guarantee better sleep. A trend toward orthosomnia, where worry about sleep scores harms sleep, is recognized. The implication for employers is that sleep programs work best when paired with scheduling practices that allow rest, and for individuals persistent sleep problems warrant a clinician visit.
9. Personalized nutrition
Maturity: emerging to expanding.
Personalized nutrition tailors dietary advice using food logs, glucose responses, microbiome tests and genetics. The PREDICT study, published in Nature Medicine in 2020, followed more than 1,000 participants and showed large person to person differences in blood sugar and fat responses to identical meals, which underpins the idea. ZOE commercialized that research in a consumer program.
Evidence that personalized plans outperform standard dietary guidance on long term outcomes is limited, and trials have shown modest benefits. Companies include ZOE, Nutrisense, Levels and digital dietitian services such as Fay. Consumers meet the trend through tests and apps. Benefits include engagement and awareness. Limits include cost and the risk of overinterpreting single glucose readings. For clinicians, standard guidance on vegetables, legumes and whole grains remains well supported.
10. Mental health and digital therapy
Maturity: expanding.
Digital mental health includes apps for meditation, coaching, cognitive behavioral therapy and virtual therapy platforms. In 2024 the FDA cleared Rejoyn, the first prescription digital therapeutic for adults with major depressive disorder, delivered through an app, which marked a milestone for regulated digital treatment. Meta analyses suggest that guided digital CBT can reduce depression and anxiety symptoms, with unguided apps showing smaller effects.
Companies include Headspace, Talkspace, Spring Health and Lyra Health, which employers and plans sponsor. Benefits include access and reduced stigma. Limits include dropout, uneven quality among the thousands of wellness apps and the need for crisis pathways. Apps work best as part of care, and severe conditions require human clinicians. For employers, the evidence favors programs that include clinical care over content only offerings.
11. Strength training and functional fitness
Maturity: established.
Resistance training improves muscle mass, bone density, balance and metabolic health. A 2022 meta analysis in the British Journal of Sports Medicine reported that muscle strengthening activities were associated with roughly 10 to 17 percent lower risks of all cause mortality, cardiovascular disease and cancer, with the lowest risk at about 30 to 60 minutes a week. The WHO recommends strengthening activities at least two days a week.
The trend appears in gym growth, home equipment, app based programs such as Tonal and Peloton’s strength classes, and guidance for older adults focused on fall prevention. Benefits are broad and costs can be low with bodyweight exercise. Limits include injury risk with poor technique and access to equipment or coaching. For employers and health plans, strength programs for older adults can support independence, and evidence for fall prevention is strong.
12. Women’s health and femtech
Maturity: expanding.
Femtech covers technology for fertility, pregnancy, postpartum care, menopause and other women’s health needs. A 2024 report from the World Economic Forum and the McKinsey Health Institute estimated that women spend about 25 percent more of their lives in poor health than men and that closing the gap could add $1 trillion a year to the global economy by 2040.
Examples include Natural Cycles, which has FDA authorization as a contraceptive, Maven Clinic’s employer sponsored virtual care and Midi Health’s menopause care. Evidence varies widely, from cleared products to trackers with limited validation. Reproductive data privacy is a serious concern, and several apps have faced regulatory action for data sharing. For employers, benefits that cover fertility and menopause meet real needs, though uptake depends on awareness and cost.
13. Workplace wellbeing
Maturity: mature market, with mixed evidence.
Workplace wellbeing programs cover mental health, fitness, financial wellness and benefits navigation. Gallup’s 2025 State of the Global Workplace report found global employee engagement at 21 percent in 2024, and the WHO and ILO have estimated that depression and anxiety cost 12 billion working days a year. Employers respond with platforms from Spring Health, Lyra Health, Headspace, Hinge Health and others.
Rigorous evidence is sobering. A randomized trial at BJ’s Wholesale Club in JAMA in 2019 found that a wellness program improved some self reported behaviors but did not change clinical measures, spending or absenteeism after 18 months. Programs targeted at specific clinical needs, such as musculoskeletal pain or diabetes prevention, have a stronger record than general wellness offerings. The implication is that workload, management quality and psychological safety shape wellbeing as much as any benefit.
14. Integrative and lifestyle medicine
Maturity: established for lifestyle, mixed for complementary therapies.
Lifestyle medicine treats chronic disease through nutrition, physical activity, sleep, stress management and social connection, supported by the American College of Lifestyle Medicine. Integrative medicine combines conventional care with complementary approaches. Evidence for lifestyle changes in hypertension, type 2 diabetes and cardiovascular risk is strong, while evidence for individual complementary therapies ranges from good, such as acupuncture for some chronic pain conditions in individual patient data meta analyses, to weak.
Examples include clinics such as Cleveland Clinic’s functional medicine center and membership practices such as Parsley Health, and group visit models for lifestyle programs. Benefits include attention to root causes and patient engagement. Limits include variable rigor, cost and the risk that unproven supplements or tests are promoted alongside proven care. Consumers should ask which parts of a program are backed by trials.
15. Sustainable and climate conscious wellness
Maturity: emerging.
This trend links personal wellbeing to environmental factors, such as plant forward diets, walkable cities, green space, clean air and heat resilience. The Lancet Countdown reports document health effects of climate change, including heat related illness, wildfire smoke and shifts in infectious disease. Research links access to green space and active transport with better health.
Examples include wellness resorts that highlight sustainability, employer programs for cycling and transit, and diet frameworks such as the EAT-Lancet planetary health diet. Benefits include co benefits for health and environment. Limits include greenwashing, where products claim sustainability without evidence, and unequal access, since many people cannot choose where they live or how they commute. For wellness businesses, credible claims need measurable practices and transparent reporting.
| Trend | Main application | Target population | Maturity | Evidence level | Major limitations |
|---|---|---|---|---|---|
| Personalized preventive care | Tailored screening | Adults | Expanding | Mixed | Cost, access |
| Longevity care | Advanced testing | Affluent adults | Emerging | Weak for add-ons | False positives |
| AI health monitoring | Risk alerts | Consumers, clinicians | Emerging | Early | Bias, validation |
| Wearables | Tracking | Consumers | Mature market | Moderate | Accuracy |
| Personalized nutrition | Diet advice | Consumers | Expanding | Limited for outcomes | Unproven benefit |
| Metabolic monitoring | Glucose, BP | At risk adults | Expanding | Strong in diabetes | Healthy-user value unclear |
| Digital mental health | CBT, coaching | Adults | Expanding | Moderate to strong in some | Engagement |
| Sleep technology | Tracking, CBT-I | Adults | Expanding | Strong for CBT-I | Tracker accuracy |
| Strength training | Fitness, aging | All ages | Established | Strong | Technique, access |
| Femtech | Reproductive health | Women | Expanding | Varies | Privacy |
| Remote monitoring | Chronic disease | Patients | Expanding | Good for hypertension | Alert burden |
| Workplace wellbeing | Employee support | Workers | Mature market | Mixed | Culture matters |
| Integrative medicine | Lifestyle, complementary | Adults | Established | Mixed | Variable claims |
| Preventive diagnostics | Risk testing | Adults | Expanding | Mixed | Overdiagnosis |
| Sustainable wellness | Environment and health | All | Emerging | Moderate | Greenwashing |
The Science Behind Emerging Wellness Practices
Evidence Based Preventive Health
The strongest evidence supports a short list. Regular physical activity lowers risk of cardiovascular disease, cancer and early death. Not smoking is the single largest preventable lever. Healthy eating patterns reduce heart disease and diabetes risk. Sleep sufficiency supports metabolic and mental health. Blood pressure and cholesterol control prevent heart attacks and strokes. Age-appropriate screening for cancers such as colorectal and breast cancer has trial support.
These findings are strong, but effect sizes vary and adherence is hard. Many studies are observational, which shows association and not proof of cause.
Emerging Technologies and Health Interventions
AI recommendations, biomarkers, wearable sensors and precision health promise individualized care. Validation is the key question. A tool must be accurate, useful for decisions and shown to improve outcomes. Unintended consequences include overtesting, anxiety and inequity if tools work best for people who are already healthy and well resourced.
| Practice | Intended benefit | Evidence category | Safety considerations |
|---|---|---|---|
| Aerobic and strength exercise | Lower disease risk | Established | Injury, medical conditions |
| Blood pressure control | Fewer heart attacks, strokes | Established | Medication monitoring |
| CBT for insomnia | Better sleep | Established | Needs engagement |
| GLP-1 therapy | Weight, cardiovascular risk | Established in approved groups | Side effects, cost |
| Continuous glucose monitoring for healthy users | Awareness | Emerging | Misinterpretation |
| Epigenetic age tests | Biological age tracking | Preliminary | Variability |
| Multi-cancer blood tests | Early detection | Investigational | False positives |
| Detox products | Cleansing | Unsupported | Possible harm |
Technology and Personalization in Everyday Wellness
Connected devices, apps, predictive analytics and virtual coaching are changing daily habits. Data quality varies, and interoperability between devices is limited. Engagement often fades after a few weeks, which limits results.
Privacy is a serious concern. Many wellness apps are not covered by HIPAA, and data may be shared with advertisers. Algorithmic bias can occur when training data underrepresent some groups. Constant monitoring can cause health anxiety, sometimes called orthosomnia in the case of sleep tracking. Using technology to support clinician advice, rather than to replace it, lowers risk.
| Technology | Application | Data collected | Personalization potential | Privacy considerations |
|---|---|---|---|---|
| Smartwatch or ring | Activity, sleep, heart rate | Biometrics | Moderate | Third-party sharing |
| Glucose sensor | Metabolic tracking | Glucose | High | Health data sensitivity |
| Nutrition app | Diet tracking | Food logs | Moderate | Advertising use |
| AI coach | Behavior guidance | Conversation, activity | High | Data retention |
| Home test kits | Hormones, microbiome | Biological samples | Moderate | Genetic data risk |
Wellness Trends Across Different Populations
Access differs by age, income, geography, gender, disability and healthcare access. Older adults benefit from strength and balance work but may face technology barriers. Low-income communities face higher chronic disease rates and less access to gyms, healthy food and preventive care. Rural areas have fewer clinicians. People with disabilities need accessible tools.
In lower resource settings, consumer wellness trends translate differently. Affordable, culturally relevant measures, such as community health workers, basic blood pressure control and nutrition programs, deliver more benefit than premium tools. Trends should adapt to local foods, languages and traditions.
| Trend | Affordability considerations | Access barriers | Potential equity impact | Evidence requirements |
|---|---|---|---|---|
| Strength training | Low cost with bodyweight | Space, knowledge | Positive | Maintain safe guidance |
| Wearables | Moderate to high | Cost, smartphone access | May widen gaps | Validation in diverse groups |
| Longevity clinics | Very high | Cost | Widens gaps | Outcome trials |
| Remote monitoring | Often covered in programs | Connectivity | Can improve rural access | Equity-focused trials |
| Personalized nutrition | Moderate to high | Cost of tests | May widen gaps | Long-term outcome data |
Wellness Myths, Commercial Claims and Evidence Gaps
Exaggerated claims are common. Longevity marketing may promise to reverse aging, though no intervention has shown that in humans. Many supplements are sold with limited evidence and little regulatory review of effectiveness. Biological age tests can differ between labs. Detox cleanses lack evidence that they remove toxins beyond what the liver and kidneys already do.
Wellness marketing and healthcare evidence follow different standards. Medical products must meet regulatory requirements. Wellness products often make general claims that avoid regulation. Consumers can protect themselves by asking whether the claim is supported by randomized trials or systematic reviews, who funded the research, whether the practitioner is licensed and what the product would cost relative to proven alternatives.
What the Next Decade May Bring to Wellness
AI supported preventive care, connected diagnostics, personalized behavioral interventions and integrated digital health are plausible developments. Regulation, reimbursement, clinical validation and data privacy will determine which become routine. Some ideas will fade, as earlier fads did.
Possible directions include insurers covering digital prevention programs, primary care incorporating wearable data and AI assisted triage. None is guaranteed. The most reliable prediction is that strong evidence for basics, such as movement, sleep, nutrition and social connection, will remain the center of wellbeing.
Sources for the trend profiles:
- WHO physical activity fact sheet
- CDC chronic disease data
- Global Wellness Institute research
- FDA AI-enabled medical devices list
Frequently Asked Questions
Q: What are the latest health and wellness trends?
A: Current trends include personalized prevention, longevity clinics, wearables, GLP-1 therapies, strength training, digital mental health, sleep technology and femtech. Evidence varies widely among them. Strength training and exercise have the strongest support.
Q: Which wellness trends are supported by science?
A: Regular physical activity, strength training, healthy eating patterns, adequate sleep, blood pressure control and CBT for insomnia have strong evidence. Many technology-based trends have partial evidence. Others remain unproven.
Q: How is AI changing personal wellness?
A: AI powers coaching apps, risk alerts and health summaries. It can scale advice, but accuracy and bias vary. Use AI features as prompts and check important issues with a clinician.
Q: What is personalized preventive healthcare?
A: It tailors screening and risk reduction to a person’s history, risk factors and preferences. It builds on guidelines and may add tools such as genetic and imaging tests. Benefit depends on whether results change decisions.
Q: Are longevity treatments scientifically proven?
A: Established prevention improves healthspan, but no treatment has been proven to reverse aging or extend human lifespan. Experimental therapies remain under study. Be cautious about claims of age reversal.
Q: How are wearables changing health monitoring?
A: Wearables give continuous data on activity, sleep and heart rhythm, and a few features have FDA clearance. Accuracy varies, and data can cause anxiety. They support, but do not replace, clinical care.
Q: What is the difference between wellness and healthcare?
A: Healthcare diagnoses and treats disease under regulated standards. Wellness promotes healthy behaviors and general wellbeing. Wellness products often make claims without regulatory review.
Q: Which wellness trends may become more common in the future?
A: Digital prevention programs, remote monitoring, AI assisted care and integrated mental health tools may expand, particularly if payers cover them. Adoption depends on evidence and cost. Trends are not guaranteed.